FGF8, fibroblast growth factor 8, 2253

N. diseases: 212; N. variants: 23
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0376634
Disease: Craniofacial Abnormalities
Craniofacial Abnormalities
0.320 GeneticVariation group BEFREE Missense, nonsense, and splice mutations in the Fibroblast Growth Factor 8(FGF8) have recently been identified in patients with hypothalamo-pituitary dysfunction and craniofacial anomalies. 24280688 2014
CUI: C0376634
Disease: Craniofacial Abnormalities
Craniofacial Abnormalities
0.320 Biomarker group BEFREE Since FGF8 maps to the same chromosomal region as FGFR2, has indeed been shown to be a ligand for FGFR2, and has an expression pattern consistent with limb and craniofacial anomalies, we have screened two kindreds with Pfeiffer syndrome that were previously linked to markers from 10q24-25 and a large number of individuals with craniosynostosis and limb anomalies for mutations in the coding sequence of FGF8. 9332670 1997
CUI: C0376634
Disease: Craniofacial Abnormalities
Craniofacial Abnormalities
0.320 Biomarker group CTD_human Fgf8 is required for anterior heart field development. 16720880 2006
CUI: C0243050
Disease: Cardiovascular Abnormalities
Cardiovascular Abnormalities
0.300 Biomarker group CTD_human Fgf8 is required for anterior heart field development. 16720880 2006
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.100 AlteredExpression group BEFREE Increased expression of FGF8 correlated significantly with higher Gleason scores (P=0.0004) and advanced tumour stage (P=0.0016). 10348350 1999
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.100 AlteredExpression group BEFREE Previously, we described cloning of three alternatively spliced mRNA forms of human FGF8, a, b, and e, of which the b form is the major expressed species in both normal and tumor prostatic epithelial cells. 9525747 1998
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.100 Biomarker group BEFREE Evaluation and Immunolocalization of BMP4 and FGF8 in Odontogenic Cyst and Tumors. 30079292 2018
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.100 AlteredExpression group BEFREE The reverse transcription-PCR amplification method, however, detected FGF8 mRNA expression in adult prostate, kidney, and testes (the tissues that were tested) and in all normal and tumor prostatic epithelial cell lines examined; although expression of both FGF8a and FGF8b was seen in kidney and testes, FGF8b appeared to be the predominantly expressed species in the prostatic tissue and cell lines analyzed by reverse transcription-PCR. 8891346 1996
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.100 AlteredExpression group BEFREE Consistent with the oncogenic characteristics of FGF-8, the corresponding mRNA was detected in the human prostate tumour cell lines LNCaP and DU145. 8645626 1996
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.100 GeneticVariation group BEFREE These regions contained representative tumor-related genes, such as the FGF8 and NPM3 genes at 10q24.32, and the LAMP1 gene at 13q34, which have been reported in connection with various tumors. 20428766 2010
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.100 AlteredExpression group BEFREE In 39 tumours there was a statistically significant negative correlation between tumour grade and FGF8 expression and a positive correlation between FGF8 and androgen receptor expression. 10343609 1999
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.100 Biomarker group BEFREE Consistent with this, FGF8 can also promote tumor growth and metastasis in mouse models. 25473897 2015
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.100 Biomarker group BEFREE In general, the increased intensity of FGF-8 staining was associated with loss of differentiation within the tumors (Bowker's test, p = 0.37). 11072239 2000
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.100 AlteredExpression group BEFREE The androgen-inducible expression of Fgf8 in this tumor controls its androgen-dependent phenotype, thus stimulating interest in this gene as a possible factor in human prostate cancer and other androgen-sensitive cancers. 16252261 2006
CUI: C0029422
Disease: Osteochondrodysplasias
Osteochondrodysplasias
0.100 Biomarker group HPO
CUI: C0575081
Disease: Gait abnormality
Gait abnormality
0.100 Biomarker group HPO
CUI: C3714756
Disease: Intellectual Disability
Intellectual Disability
0.100 Biomarker group HPO
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.050 Biomarker group BEFREE Expression of fibroblast growth factor 8 (FGF-8) is increased in several forms of hormonal cancer. 20370578 2010
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.050 GeneticVariation group BEFREE This was tested by means of fluorescent in situ hybridisation in 20 cancer specimens to map the FGF8 gene locus. 12778074 2003
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.050 Biomarker group BEFREE Thus, the FGF8 subfamily supports the development and progression of hepatocellular malignancy. 21319186 2011
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.050 Biomarker group BEFREE However, the FGF-8 receptor showed greater involvement at the beginning of the malignancy alterations. 23362007 2013
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.050 Biomarker group BEFREE To study the role of fibroblast growth factor 8 (FGF-8) in human development and malignancies, we have isolated and characterized its gene. 9366493 1997
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms
0.040 AlteredExpression group LHGDN FGF-8 is involved in bone metastasis of prostate cancer. 18386787 2008
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms
0.040 AlteredExpression group LHGDN FGF8 isoform b expression in human prostate cancer. 12778074 2003
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms
0.040 AlteredExpression group LHGDN Regulation of FGF8 expression by the androgen receptor in human prostate cancer. 12140757 2002